ONVO - Organovo Holdings, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
1.20
+0.01 (+0.84%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close1.19
Open1.18
Bid0.00 x 900
Ask0.00 x 3200
Day's Range1.14 - 1.21
52 Week Range0.91 - 2.28
Volume445,675
Avg. Volume624,757
Market Cap136.139M
Beta2.11
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • GlobeNewswirelast month

    Recent Analysis Shows Ellie Mae, Organovo, Calithera Biosciences, Whirlpool, Marathon Oil, and Infinera Market Influences — Renewed Outlook, Key Drivers of Growth

    NEW YORK, Aug. 14, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ellie ...

  • GlobeNewswirelast month

    Organovo Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    Organovo Holdings, Inc. (ONVO) (“Organovo” or the “Company”) announced the grant of inducement awards on August 14, 2018 to Dr. Steven G. Hughes, its new chief medical officer.  The inducement awards were approved by the compensation committee of the Company’s board of directors and issued as a material inducement to Dr. Hughes agreeing to join the Company in accordance with NASDAQ Listing Rule 5635(c)(4).

  • GlobeNewswirelast month

    Organovo Reports Fiscal First-Quarter 2019 Results; Company Outlines and Expands Key Clinical Development Goals

    Pre-Investigational New Drug meeting with the FDA expected to be held in calendar 2019 Lead IND program for Alpha-1-antitrypsin deficiency expected to commence IND-enabling studies in second half of calendar ...

  • ACCESSWIRElast month

    Organovo Holdings, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 9, 2018 / Organovo Holdings, Inc. (NASDAQ: ONVO ) will be discussing their earnings results in their Q1 Earnings Call to be held on August 9, 2018 at 5:00 PM Eastern ...

  • GlobeNewswire2 months ago

    Organovo Announces Appointment of Steven G. Hughes, M.D. as Chief Medical Officer

    Organovo Holdings, Inc. (ONVO) (“Organovo”) today announced that Steven G. Hughes has been named Chief Medical Officer.  Dr. Hughes is an industry veteran who brings significant experience directing clinical development and medical affairs teams at leading biopharma companies. Dr. Hughes most recently served as the Chief Clinical Development Officer at Ionis Pharmaceuticals, where he led a team that managed the global clinical development of 25 drugs across 10 therapeutic areas including cardiovascular, metabolic, oncology and rare diseases.  Previously, he held positions as Global Medical Lead, Oncology Clinical Development and Medical Director, UK & Ireland at Biogen Idec.  Dr. Hughes also held numerous senior clinical development, medical affairs and leadership positions of increasing responsibility at CSL Behring and Sanofi.  Dr. Hughes is board certified in Pharmaceutical Medicine and received his medical degree from Imperial College, London.  He also has an MBA with distinction from Imperial College Business School.

  • ACCESSWIRE2 months ago

    Free Pre-Market Technical Recap on ResMed and Three Additional Healthcare Stocks

    On Thursday, July 19, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged lower at the closing bell. Taking into consideration yesterday's market sentiment, WallStEquities.com assessed the following Healthcare equities this morning: OraSure Technologies Inc. (NASDAQ: OSUR), ResMed Inc. (NYSE: RMD), OpGen Inc. (NASDAQ: OPGN), and Organovo Holdings Inc. (NASDAQ: ONVO). On Thursday, shares in Bethlehem, Pennsylvania-based OraSure Technologies Inc. recorded a trading volume of 373,287 shares.

  • GlobeNewswire2 months ago

    Organovo Announces Release Date for Fiscal First-Quarter 2019 Financial Results

    SAN DIEGO, July 19, 2018-- Organovo Holdings, Inc. will host a conference call on Thursday, August 9, 2018 at 5:00 p.m. Eastern Time to discuss the Company's fiscal first-quarter 2019 operating and financial ...

  • ACCESSWIRE4 months ago

    Free Stock Performance Review on Organovo Holdings and Three Additional Medical Research Stocks

    LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want a free Stock Review on ONVO sign up now at www.wallstequities.com/registration. Durham, North Carolina headquartered IQVIA Holdings Inc.'s stock finished Wednesday's session 1.31% higher at $100.48 with a total trading volume of 968,866 shares. Over the last month and the previous three months, the Company's shares have advanced 4.93% and 2.19%, respectively.

  • Cirius Therapeutics' Preclinical Data Demonstrates Potential for Lead Drug Candidate MSDC-0602K in NASH
    PR Newswire5 months ago

    Cirius Therapeutics' Preclinical Data Demonstrates Potential for Lead Drug Candidate MSDC-0602K in NASH

    Late-Breaking Poster Presented at The International Liver Congress SAN DIEGO and KALAMAZOO, Mich. , April 12, 2018 /PRNewswire/ -- Cirius Therapeutics announced today that it presented a late-breaking ...

  • ACCESSWIRE7 months ago

    Organovo Holdings, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / February 8, 2018 / Organovo Holdings, Inc. (NASDAQ: ONVO ) will be discussing their earnings results in their Q3 Earnings Call to be held on February 8, 2018 at 5:00 PM Eastern ...